We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jordan Axelrad MD, MPH

Jordan E. Axelrad MD, MPH

Assistant Professor, Division of Gastroenterology, NYU Grossman School of Medicine Inflammatory Bowel Disease Center, NYU Langone Health, New York, New York

Jordan E. Axelrad, MD, MPH, is an Assistant Professor of Medicine in the Division of Gastroenterology, Department of Medicine, at NYU Grossman School of Medicine, and a gastroenterologist at the Inflammatory Bowel Disease Center at NYU Langone Health. Dr. Axelrad is also a faculty member in the Vaccine Center in the Division of Infectious Diseases and Immunology at NYU Langone Health and a member of the executive council in the New York Crohn's and Colitis Organization. Dr. Axelrad received his medical and public health degrees from Tufts University School of Medicine. He completed his internal medicine training at the Icahn School of Medicine at Mount Sinai and went on to complete fellowship training in gastroenterology at Columbia University Medical Center, serving as chief fellow. Dr. Axelrad received specialized training in clinical and translational IBD investigation, and his research in areas such as environmental factors in IBD, and in malignant and infectious complications of IBD, has been published in numerous peer-reviewed journals and presented internationally. He is the principal investigator of the institutional NYU IBD biorepository and mentors medical students, doctoral students, residents, and fellows in various research activities. His current research is funded by the Crohn’s and Colitis Foundation, the Judith and Stewart Colton Center for Autoimmunity, the New York Crohn's and Colitis Organization, and the National Institutes of Health, and focuses on IBD epidemiology, pathogenic triggers of IBD onset and flare, and ex vivo models for predicting responsiveness to IBD therapies.


Dr. Axelrad receives research grants from BioFire Diagnostics; receives consultancy fees or honorarium from BioFire Diagnostics and Janssen; and holds U.S. patent 2012/0052124A1.

Recent Contributions to PracticeUpdate:

  1. Cancer Risk in Inflammatory Bowel Disease